Kessler Foundation presents data on Ekso at World Congress of Biomechanics


RICHMOND, Calif. - Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, announced today that Kessler Foundation, a global leader in rehabilitation research, has presented preliminary data at World Congress of Biomechanics held in Boston, MA, July 5-10, showing that spinal cord injury (SCI) motor incomplete and complete users were able to actively increase step swing time, stride length and hip extension after walking with an Ekso(TM) robotic exoskeleton. Most notably, muscle activation per gait cycle increased with training and became more similar to able-bodied walking.

In an additional study, Kessler Foundation also reports on work focused on mathematically simulating human and exoskeleton interactions. The model will be useful in understanding the results of their on-going studies of intensive exoskeleton training. Kessler Foundation has been using Ekso Bionics' exoskeleton for clinical research in patients with spinal cord injury since October 2011 and recently acquired a second device to study utility and efficacy specifically for stroke survivors.

"We are seeing that robotics in rehabilitation are having an increasingly positive impact on patient outcomes, and research such as this is key to furthering such progress," said Rodger DeRose, president and chief executive officer of Kessler Foundation. "Exploring robotic exoskeletons is an exciting new avenue for our mobility researchers."

Ekso Bionics Chief Executive Officer Nathan Harding added, "It is very interesting to see that muscle activity increased in a patient with a complete spinal cord injury as they got more training. They will need more data, but this is a very intriguing result."

Ekso Bionics designs, develops, and commercializes exoskeletons, or wearable robots, which have a variety of applications in the medical, military, industrial, and consumer markets. Exoskeletons are ready-to-wear, battery-powered robots that are strapped over the user's clothing, enabling individuals to achieve mobility, strength, and endurance not otherwise possible. Ekso Bionics' lead product, Ekso(TM), is a wearable bionics suit that enables individuals with any amount of lower extremity weakness to stand up and walk over ground. Ekso is forging a new frontier in rehabilitation for people living with the consequences of stroke, spinal cord injury and other neurological conditions affecting gait.

About Kessler Foundation

 

Kessler Foundation, a major nonprofit organization in the field of disability, is a global leader in rehabilitation research that seeks to improve cognition, mobility and long-term outcomes, including employment, for people with neurological disabilities caused by diseases and injuries of the brain and spinal cord. Kessler Foundation leads the nation in funding innovative programs that expand opportunities for employment for people with disabilities. For more information, visit KesslerFoundation.org.

 



July 23, 2014


Topic Area: Press Release


Recent Posts

Must Know Recalls of 2025

For the safety of our readers, Healthcare Facilities Today has closely followed all recall notices related to the industry.


Sustainability as a Baseline in Healthcare Facilities

Hospitals can balance costs, build resilience and learn from global models for sustainable design to further their green goals.


Comanche County Memorial Hospital and Southwestern Medical Center Join to Form Partnership

The partnership will go into effect by the end of December 2025.


Choosing a Disinfectant That Kills Biofilm

Bacteria form biofilms in pipes from which cells can be released during sink use and spread outside the drains in droplets or as aerosols.


Third-Party Data Breach Case Underscores Need for Cyber Risk Management

Plaintiffs alleged negligence in safeguarding patient data; defendants denied wrongdoing but settled to avoid litigation costs.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.